Device Trial Radar · NCT01028378
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Last checked: Nov 20, 2026Latest source record: Apr 11, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
212
Actual
Start
Oct 2009
Primary completion
Apr 2012
Sponsor
- Lead sponsor
- Clinical Research Consultants, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Alcon Research; WaveLight AG
- First posted
- Dec 9, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This purpose of this study is to evaluate the safety and effectiveness of a topography-based custom ablation treatment using the ALLEGRETTO WAVE® Eye-Q 400 Hz laser system for treating myopia and hyperopia.
Conditions
- Myopia
- Hyperopia
Interventions
T-CAT topography-guided LASIK treatment with the Allegretto Wave Eye-Q 400 Hz Excimer LaserDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) +/- 0.50 DTime frame: 12 month
- Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) +/- 1.00 DTime frame: 12 month
- Percentage of Eyes With Manifest Refraction Spherical Equivalent (MRSE) +/- 2.00 DTime frame: 12 month
6 more outcomes with a free account
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Milauskas Eye Institute
La Quinta, California
Gordon & Weiss Vision Institute
San Diego, California
Woolfson Eye Institute
Atlanta, Georgia
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.